Shares of AdvanSix Inc (NYSE:ASIX) have received a consensus broker rating score of 2.00 (Buy) from the two brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company.
Brokers have set a one year consensus price target of $33.50 for the company and are predicting that the company will post $0.39 EPS for the current quarter, according to Zacks. Zacks has also assigned AdvanSix an industry rank of 170 out of 256 based on the ratings given to related companies.
Several analysts recently commented on the stock. ValuEngine downgraded shares of AdvanSix from a “hold” rating to a “sell” rating in a research report on Friday, May 24th. Zacks Investment Research downgraded shares of AdvanSix from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 27th.
AdvanSix (NYSE:ASIX) last issued its earnings results on Friday, May 3rd. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.29. AdvanSix had a net margin of 5.09% and a return on equity of 17.96%. The business had revenue of $314.90 million during the quarter, compared to analysts’ expectations of $340.87 million. During the same quarter in the prior year, the business posted $0.37 EPS. The company’s revenue for the quarter was down 12.3% on a year-over-year basis. Analysts expect that AdvanSix will post 2.25 earnings per share for the current year.
In other AdvanSix news, Director Michael Marberry purchased 3,700 shares of AdvanSix stock in a transaction that occurred on Monday, May 20th. The stock was purchased at an average price of $26.99 per share, for a total transaction of $99,863.00. Following the transaction, the director now directly owns 39,996 shares in the company, valued at $1,079,492.04. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel F. Sansone acquired 4,000 shares of the business’s stock in a transaction on Friday, May 17th. The shares were purchased at an average price of $27.37 per share, with a total value of $109,480.00. Following the transaction, the director now owns 18,861 shares in the company, valued at approximately $516,225.57. The disclosure for this purchase can be found here. 0.56% of the stock is owned by corporate insiders.
Institutional investors have recently made changes to their positions in the business. Royal London Asset Management Ltd. purchased a new position in AdvanSix during the 1st quarter worth $39,000. NumerixS Investment Technologies Inc raised its position in AdvanSix by 60.0% during the 4th quarter. NumerixS Investment Technologies Inc now owns 1,600 shares of the company’s stock worth $39,000 after buying an additional 600 shares during the last quarter. O Shaughnessy Asset Management LLC raised its position in AdvanSix by 18.2% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 2,739 shares of the company’s stock worth $67,000 after buying an additional 422 shares during the last quarter. Quantamental Technologies LLC purchased a new position in AdvanSix during the 1st quarter worth $80,000. Finally, BNP Paribas Arbitrage SA raised its position in AdvanSix by 298.1% during the 1st quarter. BNP Paribas Arbitrage SA now owns 6,334 shares of the company’s stock worth $181,000 after buying an additional 4,743 shares during the last quarter. Institutional investors own 83.09% of the company’s stock.
AdvanSix Inc manufactures and sells polymer resins. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce engineered plastics, fibers, filaments, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone, which is used by customers in the production of adhesives, paints, coatings, solvents, herbicides, and other engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, cyclohexanol, acetaldehyde oxime, 2-pentanone oxime, sulfuric acid, ammonia, and carbon dioxide.
See Also: Find a Trading Strategy That Works
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.